Pieris Pharmaceuticals Inc. (PIRS) Gain 41.20% YTD: Chances Are, Buyers Will Win the Tug-of-War
Pieris Pharmaceuticals Inc. (NASDAQ:PIRS) previous close was $3.80 while the outstanding shares total 56.30M. The firm has a beta of 1.13. PIRS’s shares traded lower